Delivering High-Quality Cancer Care Charting a New Course for a System in Crisis, (National Academies Press, 2013, OpenBook and .pdf format, 360p.). Ordering information for a print copy is available at the site. Note: NAP requires free registration before providing a .pdf copy.
September 12, 2013
November 5, 2012
CAAR – US Centers for Medicare and Medicaid Services Article – November 5, 2012
“Linking Medicare, Medicaid, and Cancer Registry Data to Study the Burden of Cancers in West Virginia,” by Pramit A. Nadpara and Suresh S. Madhavan (Medicare & Medicaid Research Review, Vol. 2, No. 4, November 2012, .pdf format, 25p.).
www.cms.gov/Research-Statistics-Data-and-Systems/Research/MMRR/MMRR-Published-Articles.html
Comments Off
August 1, 2012
CAAR – US Centers for Medicare and Medicaid Services Articles – August 1, 2012
A. “Cancer Outcomes in Low-Income Elders: Is There An Advantage to Being on Medicaid?” by Siran M. Koroukian, Paul M. Bakaki, Cynthia Owusu, Craig C. Earle, and Gregory S. Cooper (Medicare and Medicaid Research Review, Vol. 2, No. 2, 2012 Q2, .pdf format, 22p.).
B. “Linkages Between Utilization of Prostate Surgical Pathology Services and Physician Self-Referral,” by Jean M. Mitchell (Medicare and Medicaid Research Review, Vol. 2, No. 3, 2012 Q3, .pdf format, 18p.).
Comments Off
June 29, 2012
CAAR – Lancet Oncology Article Abstracts – June 29, 2012
A. “Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301),” by Dr. Shinji Atagi, Masaaki Kawahara, Akira Yokoyama, Hiroaki Okamoto, Nobuyuki Yamamoto, Yuichiro Ohe, Toshiyuki Sawa, Satoshi Ishikura, Taro Shibata, Haruhiko Fukuda, Nagahiro Saijo, and Tomohide Tamura (Vol. 13, No. 7, July 2012, p. 671-678).
www.thelancet.com/journals/lanonc/article/PIIS1470-2045(12)70139-0/abstract
B. “Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial,” by Wolfgang Wick, Michael Platten, Christoph Meisner, Jorg Felsberg, Ghazaleh Tabatabai, Matthias Simon, Guido Nikkhah, Kirsten Papsdorf, Joachim P. Steinbach, Michael Sabel, Stephanie E. Combs, Jan Vesper, Christian Braun, Jurgen Meixensberger, Ralf Ketter, Regine Mayer-Steinacker, Guido Reifenberger, and Michael Weller, for the NOA-08 Study Group of the Neuro-oncology Working Group (NOA) of the German Cancer Society (Vol. 13, No. 7, July 2012, p. 707-715).
www.thelancet.com/journals/lanonc/article/PIIS1470-2045(12)70164-X/abstract
Comments Off
